SuperworthvTv Therapeutics market cap VTVT
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $101M
- Highest close in our data
- $266.4M
- Oct 2015
vTv Therapeutics is worth $101M at the close on Oct 23, 2026, at $25.55 a share.
That is up 51% over the last year and down 15% over five years.
Its highest close in our data was $266.4M in Oct 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $101M | $101M | $162.2M | −32% |
| 2025 | $149.3M | $44M | $149.3M | +255% |
| 2024 | $42.1M | $21.6M | $84M | +40% |
| 2023 | $30.1M | $22.9M | $105.6M | −57% |
| 2022 | $69.3M | $38.3M | $127.6M | −23% |
| 2021 | $89.6M | $89.6M | $233.1M | −35% |
| 2020 | $137.4M | $109.6M | $229M | +28% |
| 2019 | $107.2M | $59.9M | $119.4M | +16% |
| 2018 | $92.5M | $24.9M | $243.5M | −53% |
| 2017 | $197.2M | $136.2M | $255M | +24% |
| 2016 | $158.5M | $158.2M | $239.9M | −29% |
| 2015 | $223.5M | $211.3M | $266.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest vTv Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VTVTvTv Therapeutics | $101M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on vTv Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.